Podcasts about drug administration

What if your hormone imbalance has nothing to do with your hormones and everything to do with the light in your house? Health detective and certified quantum biology practitioner Sarah Kleiner joins us to break down one of the most underconversed topics in women's midlife health: how your light environment is directly disrupting your hormones, your metabolism, your thyroid, your gut, and your sleep... and what you can actually do about it today. Sarah shares her deeply personal journey through irregular cycles, two miscarriages, two failed IVF rounds, and eventually a successful pregnancy at 43, all made possible by rebuilding her health from the circadian rhythm up. She explains why going carnivore helped and then hurt her, how artificial light at night is functionally the same as not sleeping, and why estrogen dominance might actually be a lighting problem. We also dig into the nuanced conversation around HRT: the peer pressure to do it, the risks of doing it without understanding your detox pathways and genetics, and why both "HRT causes cancer" and "HRT doesn't cause cancer" are incomplete statements. Sarah's philosophy? Fix the terrain first, then make an informed decision. If you have ever felt like you are doing everything right and still not feeling well, this episode will give you a new lens to look through and a clear place to start.   Learn More About Sarah Kleiner Instagram ➜ https://www.instagram.com/SarahKleinerWellness Website ➜  https://SarahKleinerWellness.com  Thank you to our show sponsors! BIOPTIMIZERS: Get the digestive enzymes I take with every meal here https://www.bioptimizers.com/nataliejill Free Gifts for being a listener of Midlife Conversations! Mastering the Midlife Midsection Guide: https://theflatbellyguide.com/ Age Optimizing and Supplement Guide: https://ageoptimizer.com   Connect with me on social media! Instagram: www.Instagram.com/Nataliejllfit Facebook: www.Facebook.com/Nataliejillfit   For advertising inquiries: https://www.category3.ca/  Disclaimer: Information provided in the Midlife Conversations podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before making any changes to your current regimen.  Information provided in this podcast and the use of any products or services related to this podcast does not create a client-patient relationship between you and the host of Midlife Conversations or you and any doctor or provider interviewed and featured on this show. Information and statements may have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease. Advertising Disclosure: Some episodes of Midlife Conversations may be sponsored by products or services discussed during the show. The host may receive compensation for such advertisements or if you purchase products through affiliate links. Opinions expressed about products or services are those of the host and/or guests and do not necessarily reflect the views of any sponsor. Sponsorship does not imply endorsement of any product or service by healthcare professionals featured on this podcast.

Why does one meal a day work at first—then suddenly stall? Episode #249

I am joined by Charles River's newest Senior Vice President, Chief Scientific & Innovation Officer Dr. Namandjé Bumpus to discuss her amazing career. From hands on research as Professor and Director of the Department of Pharmacology and Molecular Sciences at Johns Hopkins University School of Medicine, to Chief Scientist and later Principal Deputy Commissioner at the US Food and Drug Administration, Dr. Bumpus has seen every angle of the industry. She joins me to discuss her research, the discipline she learned from her father's boxing gym, and her perspective on the industry today. 

Hey Mama,  It never fails that the majority of my stress stems from me not meeting my own expectations. My toxic trait is trying to fit one more thing in a time block that just doesn't have space, and then I find myself flying by the seat of my pants to get it done. For me, this worked for YEARS, but recently, my body has been telling me I need to create more space to manage the amount of stress in our current season. I am here to tell you I will be taking a brief pause of releasing new episodes, and will be providing updates to my listeners through my VIP email list. If you haven't  joined already,  you can find sign up here: https://bit.ly/naturalwellnessinsider  I will also continue connecting with you through our VIP Facebook group. You can join our free community here: https://www.facebook.com/groups/1789472588229094 . Be sure to answer the membership questions to be admitted into the group! Lastly, please consider keeping me in your prayers, and if you have any special prayer requests I can be praying for, please send them to me here: naturalwellnessforbusymoms@gmail.com. I'll be back with new content for you soon! For His Glory, Christen   I would love to hear from you!  >>Leave a Review >>Connect with me:   Sign Up for Manage In The Moment Coaching Call: https://bit.ly/ManageStressInTheMoment   Email me : naturalwellnessforbusymoms@gmail.com  Sign Up to Become an Insider: https://bit.ly/naturalwellnessinsider  Join Our FREE Facebook Community:https://www.facebook.com/groups/1789472588229094  >>Find Related Products Here: https://bit.ly/m/Natural-Wellness-for-Busy-Moms  >> These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. >>I make a small commission when using the links above to purchase items.

It's Friday, March 13th, A.D. 2026. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Adam McManus Why some Iranians dance during war Why are some Iranians dancing while war is unfolding in their country? For more than 47 years, the Islamic regime ruling Iran has governed through fear, oppression, and bloodshed, reports International Christian Concern. The hands of this regime are stained with the blood of thousands of Iranian and American citizens. It has been one of the world's leading sponsors of terrorism, spreading violence far beyond Iran's borders. At home, it has relentlessly persecuted Christians — executing some, imprisoning many, and forcing countless others into exile. Believers have been torn from their families, their homes, and their homeland, scattered across the world simply because they chose to follow Jesus Christ. When some Iranians celebrate or dance these days, it is not because they love war. It is because they have lived for decades under a darkness that few outside the country can fully comprehend. For many Iranians, these moments carry the fragile hope that the long night of oppression may finally be nearing its end. And freedom might be dawning once again. Congress hopes to Safeguard Women from Chemical Abortion On Wednesday, Republican Senator Josh Hawley of Missouri took to the podium in the Senate Judiciary hearing room to deliver a clear message: the abortion pill Mifepristone is not just risky — it's “inherently dangerous.” And it's up to Congress to regulate it, reports The Washington Stand. At a press conference, the Missouri senator unveiled his new legislation, the Safeguarding Women from Chemical Abortion Act. This bill seeks to strip Mifepristone — the drug responsible for the majority of U.S. abortions — of its longstanding approval from the Food and Drug Administration. According to recent data from the Guttmacher Institute, chemical abortions made up 63% of all abortions in 2023, with the trend only accelerating in the years since. Senator Hawley didn't hold back, blasting the FDA for letting mail-order shipments flood the country, wiping out state-level protections for the unborn and leaving women to face severe complications. HAWLEY: “In 11% of cases, women who take the drug, Mifepristone for use in an abortion experience a serious adverse health event. Now, that's the technical term. What it means, in practice, is internal infections, sepsis, hemorrhaging, a trip to the emergency room, a life-threatening condition. In 11% of cases!” Hawley added, “It is time for Congress to do something about this racket, And it is a racket. It is time for Congress to ban the use of Mifepristone for abortion, and it is time for Congress to give the victims — the survivors — … the right to recover.” He framed the fight as a double victory: shielding vulnerable women from what many see as a profit-driven chemical experiment and protecting unborn life when the courts and agencies will not. Call your Congressman today and urge him or her to vote for The Safeguarding Women from Chemical Abortion Act. The number is 202-224-3121. That's 202-224-3121. You can call and get a live operator 24 hours a day, 7 days a week and simply leave a message. The manufacturers and distributors of this heinous Abortion Kill Pill are well described in Isaiah 59:7. “Their feet rush into sin; they are swift to shed innocent blood. They pursue evil schemes; acts of violence mark their ways.” Armed man rammed truck into Michigan synagogue On Thursday, authorities say a man, armed with a rifle, rammed his truck into Temple Israel in West Bloomfield, Michigan, before the vehicle caught fire, prompting an active shooter response, reports NewsNation. Oakland County Sheriff Michael Bouchard said the synagogue's security team engaged the suspect with gunfire after he breached the building and drove down a hallway. The suspect was later found dead. His body was badly burned. BOUCHARD: “No kids, this is the important thing, no kids or no staff was injured whatsoever. One of the lead security people was hit by the car and was taken to the hospital for treatment. That individual should be okay.” The sheriff said the suspect appears to have been the only person in the vehicle. CNN host makes humiliating on-air correction after getting NYC terror attack story wrong During a “Stop the Islamic Takeover of New York City” rally on Saturday, two men were arrested for throwing improvised explosive devices at anti-Islam protesters. Authorities later discovered these men were inspired by the Islamic State terrorist group. The incident took place outside Gracie Mansion, the official residence of New York Democratic Mayor Zohran Mamdani. However, CNN's Abby Phillip, host of “NewsNight,” claimed on Tuesday that the men were not targeting the crowd, but the mayor, a Muslim himself, reports The Western Journal. PHILLIP: “Two Republicans say Muslims don't belong here after an attempted terror attack on New York Mayor Zohran Mamdami.” Samuel Short wrote, “The intent was obvious as CNN and Phillip would love to blame anyone who criticizes Islam as a violent terrorist. Oh, the irony.” On Wednesday morning, Phillip published a correction on the social media platform X. She also issued a correction on air Wednesday night. PHILIP: “This morning I issued a correction first thing in the morning, on X, for a mistake that I made in last night's show. But I also wanted to do so on air as well. “I incorrectly said that the bombs that were thrown by ISIS-inspired suspects in New York over the weekend were directed at Mayor Mamdani. They were not. I failed to catch and correct that mistake in real time, and I take full responsibility for that.” Former Southern Baptist Convention President entered hospice Former Southern Baptist Convention President Steve Gaines, age 68, has entered hospice care, over two years after he was diagnosed with kidney cancer, reports The Christian Post. Bellevue Baptist Church Pastor Ben Mandrell, who replaced Gaines as lead pastor of the Cordova, Tennessee-based megachurch last year, wrote a letter to the congregation earlier this week explaining the situation. He wrote, “Steve has faithfully served the Lord and shepherded so many people through the years. He's been a great pastor, mentor and friend. Let's honor him and his family by lifting them up before the Lord.” Butler Bill, which prohibited teaching evolution, signed into law And finally, on this day, March 13, 1925, Tennessee Governor Austin Peay signed the "Butler Bill” which prohibited the teaching of the false theory of macro evolution in public schools. The law was introduced by Tennessee House of  Representatives member John Washington Butler, for whom the law was named. The law was challenged and upheld later that year in a famous trial in Dayton, Tennessee called the Scopes Trial which involved a raucous confrontation between prosecution attorney and Christian leader, William Jennings Bryan, and prominent defense attorney and religious agnostic, Clarence Darrow. On parental rights, Bryan said, “The parents have a right to say that no teacher, paid by their money, shall rob their children of faith in God.” On the nature of evolution, Bryan said, "The first objection to Darwinism is that it is only a guess and was never anything more. It is millions of guesses strung together.” And, on his Christian worldview, Bryan said, "I would rather begin with God and reason down than begin with a piece of dirt and reason up.” Sadly, William Jennings Bryan died five days after the Scopes Trial concluded. The Butler Law was not repealed until 1967. Genesis 1:1 declares, “In the beginning, God created the heavens and the Earth.” Close And that's The Worldview on this Friday, March 13th, in the year of our Lord 2026. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  Plus, you can get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman and Editor-in-Chief Nielsen Hobbs discuss potential directions for the US Food and Drug Administration's Center for Biologics Evaluation and Research after the departure of Director Vinay Prasad (:32), including similarities between the center's leadership issues and the staffing problems in the Harry Potter saga's Hogwarts School of Witchcraft and Wizardry (7:48), as well as the potential policy implications (10:11). They also discuss the contributions of the agency's Real-Time Oncology Review (RTOR) pilot program to the quick reviews of two Commissioner's National Priority Voucher (CNPV) awardees (17:19). More On These Topics From The Pink Sheet US FDA's Vinay Prasad, Controversial CBER Director, Leaving In April: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fdas-vinay-prasad-controversial-cber-director-leaving-in-april-DJO7ACE73RCNTLZKQWCN2S26LM/ US FDA's CNPV Approvals Ride RTOR Pilot's Coattails: https://insights.citeline.com/pink-sheet/pathways-and-standards/review-pathways/us-fdas-cnpv-approvals-ride-rtor-pilots-coattails-3HEGU5MDWJEG7OYHSZQR6TE5NM/

Health and Human Services Secretary Robert F. Kennedy Jr. had another tough week. In addition to Kennedy having surgery on a torn rotator cuff, the nomination of his ally to become surgeon general is teetering in the Senate, the controversial head of the Food and Drug Administration's vaccine center is resigning next month, and a new survey shows Americans trust government health officials less than they do former Biden official Anthony Fauci. Meanwhile, the Trump administration's fraud crackdown is reaching private Medicare insurance plans. Anna Edney of Bloomberg News, Shefali Luthra of The 19th, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News' Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Andy Schneider of Georgetown University about the Trump administration's crackdown on Medicaid fraud in Democratic-led states.  Visit our website for a transcript of this episode.Plus, for "extra credit" the panelists suggest health policy stories they read this week that they think you should read, too: Julie Rovner: The Marshall Project's "The Harrowing Journey Home for Families Leaving Immigration Detention," by Shannon Heffernan, Jesse Bogan, and Anna Flagg.  Anna Edney: The Wall Street Journal's "The Boom in Autism Therapy Is Medicaid's Fastest-Growing Jackpot," by Christopher Weaver, Tom McGinty, and Anna Wilde Mathews.  Shefali Luthra: The New York Times' "States Move To Limit Access to H.I.V. Treatment," by Apoorva Mandavilli.  Joanne Kenen: The Idaho Capital Sun's "988 Ended His Call. Now an Idaho Teen Is Pushing for a Fix to State's Parental Consent Law," by Laura Guido.  

  You finally got answers. You have a diagnosis. You're on medication. So why do you still feel so tired? If you've ever walked out of a doctor's appointment feeling dismissed, confused, or just plain stuck, this episode is for you. The truth is, a "normal" lab result doesn't always mean you're okay — and thyroid medication alone may not be the whole answer. In episode 190, Esther answers the questions her listeners ask most, pulled straight from the most downloaded episodes of Health with Hashimoto's. If you've been wondering why you're still tired on thyroid medication, this episode gives you real answers and a clearer path forward. In this episode, you'll learn: Why your TSH can look fine while your cells are still starving for thyroid hormone The three root causes of Hashimoto's and the eight most common triggers What most women are told at diagnosis that simply isn't the whole truth — and what to know instead Hit play and get the clarity you've been looking for.   JOIN THE HEALTH WITH HASHIMOTO'S COMMUNITY Unlock your wellness journey with the free Health with Hashimoto's community! Join a supportive community that's here for you every step of the way. The Health with Hashimoto's community is on Skool: https://www.skool.com/health-with-hashimotos/about   Find all links on my resource page: https://healthwithhashimotos.com/resources/   ABOUT THE PODCAST & ESTHER: The Health with Hashimoto's podcast will help you explore the root causes of your autoimmune condition and discover holistic solutions to address your Hashimoto's thyroiditis. It is hosted by Esther Yunkin, a registered nurse, holistic health educator, and Hashimoto's warrior.   This podcast is for informational and educational purposes. Please discuss any questions or concerns with your healthcare professional. These statements have not been evaluated by the Food and Drug Administration. Products mentioned are not intended to diagnose, treat, cure or prevent any disease.

Families of children with the ultra-rare mitochondrial disorder pyruvate dehydrogenase complex deficiency, or PDCD, are fighting to get the U.S. Food and Drug Administration to provide a path to approval Saol Therapeutics' experimental therapy without requiring another trial. The agency refused to approve its therapy late last year, despite gains in survival, biomarkers, and real‑world function that parents say the trial missed. We spoke with Hope for PDCD Founder and CEO Frances Pimentel and parent board member Kim Higbee about the community's reaction, the gap between patient experience and study endpoints, and the struggle to get regulators to align their actions with their stated commitments to ultra‑rare disease patients.

In this episode of Lab Rats to Unicorns, John Flavin sits down with Dr. Robert Califf, physician-scientist and two-time Commissioner of the U.S. Food and Drug Administration under Presidents Barack Obama and Joe Biden. A cardiologist by training and longtime leader in clinical research, Dr. Califf has spent his career at the intersection of medicine, technology, regulation, and public service. From founding the Duke Clinical Research Institute to guiding the FDA through the COVID-19 pandemic, Dr. Califf brings a rare perspective on how science becomes medicine—and how policy, politics, and evidence shape what ultimately reaches patients. He reflects on the early days of cardiology breakthroughs, the birth of large-scale clinical trials, and the responsibility regulators carry in balancing innovation with safety. The conversation explores translational medicine, the realities of uncertainty in public health, the evolving role of AI in healthcare, and the global competition shaping the future of biomedical innovation. At its core, this episode is about decision-making under pressure—and the systems required to ensure that groundbreaking ideas translate into measurable benefit for patients.

The Food and Drug Administration's controversial regulator is set to exit, amid more criticisms that the agency is stifling promising treatments. Meantime, the AI company Anthropic sues the Pentagon, after the Trump administration labels it a "supply chain risk" after a dispute over surveillance and autonomous weapons. Learn more about your ad choices. Visit megaphone.fm/adchoices

Grab Mat's book 'Cracking the Man Code' at https://go.lifemasteryinstitute.com/i/?p=njill&w=ctmc2026-bookorder where he has loaded up over $300 in bonuses for our listeners. What if the reason you keep losing the spark has nothing to do with your partner and everything to do with an energy you have been running on autopilot for years? In this conversation, relationship expert and author Mat Boggs, talks about something I do not think gets enough airtime: why so many midlife women find themselves feeling disconnected from their partners or stuck in a cycle of crashed relationships, and what is actually going on beneath the surface. Mat's story is one of the most honest ones I have heard from a man on this subject. He once ranked second-to-last in a voting exercise where 50 women evaluated 50 men on nothing but the energy they had been showing up with for four days. That crushing feedback became the launching pad for everything he now teaches about love, attraction, and authentic connection. We got into the concept of polarity, which is the interplay between masculine and feminine energy, and how so many of us who thrive in our masculine at work unknowingly bring that same energy home and kill the attraction in our closest relationships. We talked about what actually makes a woman magnetic at any age (hint: it is not about the number on the scale or the gray in your hair). And we went deep on what to do if your relationship has started feeling like a roommate situation. Mat also shared the appreciation practice that has transformed marriages, a practical three-step method for holding your standards without pushing someone away, and why the pressure of asking 'is this the one?' might be the very thing keeping you stuck. This one is for every woman who has ever wondered why love feels harder than it should, and who is ready to hear that the answer might already be inside her.   • Grab Mat's book 'Cracking the Man Code' at https://go.lifemasteryinstitute.com/i/?p=njill&w=ctmc2026-bookorder where he has loaded up over $300 in bonuses for our listeners. • 089: Bouncing Back from Massive Setbacks with Mary Morrissey Catch the full episode on YOUTUBE HERE: https://bit.ly/MidlifeConversationsYouTube    Learn More About Mat Boggs Instagram ➜ https://www.instagram.com/mathewboggs Website ➜  http://crackingthemancode.com/ Thank you to our show sponsors! KION: Visit https://getkion.com/nataliejill for 20% off your order of essential amino acids  Free Gifts for being a listener of Midlife Conversations! Mastering the Midlife Midsection Guide: https://theflatbellyguide.com/ Age Optimizing and Supplement Guide: https://ageoptimizer.com   Connect with me on social media! Instagram: www.Instagram.com/Nataliejllfit Facebook: www.Facebook.com/Nataliejillfit   For advertising inquiries: https://www.category3.ca/  Disclaimer: Information provided in the Midlife Conversations podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before making any changes to your current regimen.  Information provided in this podcast and the use of any products or services related to this podcast does not create a client-patient relationship between you and the host of Midlife Conversations or you and any doctor or provider interviewed and featured on this show. Information and statements may have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease. Advertising Disclosure: Some episodes of Midlife Conversations may be sponsored by products or services discussed during the show. The host may receive compensation for such advertisements or if you purchase products through affiliate links. Opinions expressed about products or services are those of the host and/or guests and do not necessarily reflect the views of any sponsor. Sponsorship does not imply endorsement of any product or service by healthcare professionals featured on this podcast.

Why do we keep eating when we're not physically hungry? Episode #248

Hey Mama,  Last week, it became clear that if you want to learn how to manage stress naturally as an overstimulated, busy mom, then movement is essential.  You may be wondering, how do I find time for exercise with the busyness of motherhood?  Join me as we look back to part 2 of my interview with Certified Fitness Instructor and Certified Natural Health Practitioner, and sister in Christ, Annemarie Dalton for practical ways to prioritize exercise as a busy mom.   For His Glory, Christen   I would love to hear from you!  >>Leave a Review >>Connect with me:   Sign Up for Manage In The Moment Coaching Call: https://bit.ly/ManageStressInTheMoment   Email me : naturalwellnessforbusymoms@gmail.com  Sign Up to Become an Insider: https://bit.ly/naturalwellnessinsider  Join Our FREE Facebook Community:https://www.facebook.com/groups/1789472588229094  >>Find Related Products Here: https://bit.ly/m/Natural-Wellness-for-Busy-Moms  >> These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. >>I make a small commission when using the links above to purchase items.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of significant events and trends shaping the industry landscape, offering insight into the dynamic interplay between scientific innovation, regulatory challenges, and strategic growth.Starting with the recent departure of Vinay Prasad from the U.S. Food and Drug Administration, particularly from his role as director of the Center for Biologics Evaluation and Research (CBER). Prasad's tenure, though brief, left an indelible mark characterized by controversy and debate over regulatory decisions. His leadership coincided with significant advancements in biologics and gene editing technologies, like CRISPR, highlighting the complexities in balancing innovation with safety standards. Under Prasad's guidance, the FDA faced challenges in navigating these rapid advancements while maintaining rigorous oversight to ensure that new therapies are both effective and safe for public use. Prasad's resignation signals potential shifts in regulatory philosophy at CBER. The biotech industry is watching closely to see how new leadership will influence ongoing and future evaluations of biologics. The change presents an opportunity to reassess how regulatory bodies can better adapt to scientific advancements while ensuring that patient safety remains paramount. The issues faced during Prasad's tenure underscore the need for transparent decision-making and open communication with stakeholders, which are vital for maintaining trust in regulatory processes.Meanwhile, Pfizer has made a strategic entry into the Chinese obesity market with the approval of a GLP-1 drug developed alongside Sciwind Biosciences. This approval represents not only a significant step for Pfizer but also underscores a broader global focus on obesity management. The efficacy of GLP-1 receptor agonists in weight regulation has opened up new market opportunities, highlighting the growing importance of metabolic health solutions in addressing public health challenges.In other news, Johnson & Johnson's Tecvayli-Darzalex combination therapy has received its third national priority recognition from the FDA for treating multiple myeloma. This recognition reflects promising Phase 3 trial results and underscores the critical role of innovative combination therapies in improving outcomes for complex hematologic malignancies. The success of such therapies illustrates how targeted approaches can significantly enhance treatment efficacy and patient quality of life.Strategic acquisitions continue to reshape industry dynamics. Servier's $2.5 billion acquisition of Day One Biopharmaceuticals aims to strengthen its rare cancer portfolio, including a promising glioma drug, Ojemda. This move highlights Servier's commitment to addressing unmet needs in pediatric oncology and rare diseases, emphasizing a broader industry trend towards focusing on niche therapeutic areas with high potential impact.Regulatory activities are gaining momentum as well, with the FDA set to end a nine-month hiatus in advisory committee meetings by reviewing AstraZeneca's oral selective estrogen receptor degrader Truqa. As AstraZeneca seeks to enhance its oncology pipeline, this review signals ongoing innovation in hormone-based cancer therapies and reflects a renewed emphasis on bringing novel treatments to market efficiently.Additionally, Glenmark Pharmaceuticals has achieved a significant milestone with FDA approval for its generic version of GSK's asthma inhaler Flovent. This development exemplifies efforts to improve access to respiratory treatments by providing cost-effective alternatives to branded medications, potentially reducing healthcare costs while enhancing patient access.On an international scale, Taiwan has announced a substantial investment plan aimed at bolstering its drugSupport the show

On March 5, initial findings from a new California study examining ways to improve produce safety—particularly on the Central Coast—were unveiled. The multi-year study was conducted by the U.S. Food and Drug Administration in partnership with the Western Center for Food Safety at the University of California, Davis, the California Department of Food and Agriculture, and agricultural stakeholders across the region.Central Coast cattle ranchers are among those stakeholders. In this episode, we are joined by Jack Rice, owner of Western Resource Strategies LLC, to discuss why ranchers have a seat at the table, how this collaborative study came together, and his takeaways from the newly released findings.Episode Resources: Constituent Update— FDA and Partners in the Central Coast Agricultural Region of California Share Findings from Multi-year Environmental StudyConnect with the RTAP team at calcattlemenfoundation.org/RTAPText us your comments, feedback and episode ideas!

"The disease is increasingly managed as a chronic condition rather than a diagnosis with an immediate terminal outcome. Particularly, with earlier and more effective and sustained treatment options, we can make this disease a very chronic, long-term, livable condition. I want to make sure that patients are aware that this is not a death sentence. This is something that patients can live with for the long term," Ann McNeill, RN, MSN, APN, nurse practitioner at the John Theurer Cancer Center at Jersey Shore University Medical Center in Neptune, NJ, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about long-term multiple myeloma considerations for oncology nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by March 6, 2027. Ann McNeill is on the speakers' bureau for Pfizer. This financial relationship has been mitigated. All other planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to management of long-term side effects related to multiple myeloma and treatment. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 401: Multiple Myeloma Treatment Considerations for Oncology Nurses Episode 398: An Overview of Multiple Myeloma for Oncology Nurses Episode 339: A Lesson on Labs: How to Monitor and Educate Patients With Cancer Episode 201: Which Survivorship Care Model Is Right for Your Patient? ONS Voice articles: Effective Care Transitions Are Essential for New Multiple Myeloma Treatments Infection Prevention for Oncology Nurses Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations Nurse-Led Survivorship Programs Sexual Considerations for Patients With Cancer Oncology Nursing Forum articles:  A Qualitative Study of the Experiences of Living With Multiple Myeloma Changes in Health-Related Quality of Life During Multiple Myeloma Treatment: A Qualitative Interview Study ONS book: Multiple Myeloma: A Textbook for Nurses (third edition) ONS Huddle Cards: Pain Management Sexuality Survivorship Care Plan ONS Learning Libraries: Hematology, Cellular Therapy, and Stem Cell Transplantation Survivorship ONS Symptom Intervention resources: Chronic Pain Fatigue Peripheral Neuropathy American Cancer Society: Living as a Multiple Myeloma Survivor Blood Cancer United: Resources for Healthcare Professionals International Myeloma Foundation: Resources and Support for the Myeloma Community Multiple Myeloma Research Foundation: Empower Patients and the Community To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We do consider myeloma an incurable hematologic malignancy, even though we have had improvements in survival. But just like for any malignancy, our goal is to maximize survival. We want to eliminate as many myeloma cells as we possibly can. And subsequently, we want to improve the quality of life for these patients in the long term. So those are basically our treatment goals. That's what we think of when we're treating patients all throughout their treatment journey." TS 1:39 "It is very typical for patients along their journey to have received several lines of therapy. I think it's important to realize that the cells acquire new mutations, making them more resistant to these further subsequent lines of therapy. We see quicker, more aggressive relapses in those patients with multiple prior lines of therapy. We can see an increase in the CRAB symptoms, which are the calcium elevations, the renal dysfunction, profound anemia, and even bone disease. We can see a rapid rise in the monoclonal protein in the labs or even a very rapid rise in the involved light chain in that serum free light chain assay, so it's important to monitor these labs." TS 9:14 "All oncology nurses are focusing on these survivorship plans now. And I think that's a great thing when you think about a diagnosis of cancer and a survivorship plan, because it means these patients are living a longer time. We still look at long-term health maintenance guidelines depending on the patient's sex and their age. ... I think preventing infection is always going to be something absolutely on the forefront in our survivorship plan with myeloma. I mean, myeloma is an immune system malignancy. The treatments that we have given patients can sometimes, especially in later life therapies, further compromise the immune system. So, we're always looking to prevent serious infection." TS 12:46 "Patients get treatment, especially induction therapy. They may or may not get transplant. They may have been on a very minor maintenance schedule, depending on their age. And they feel really well. And then they decide not to return for their follow-up because they feel so good. I think nurses are critical in the communication aspect of the patient-provider aspect. So, nurses are really the key means of communication. The providers are absolutely important—the physicians, the nurse practitioners and every other member of the team—but I think the nurses have a really special rapport with patients. They're usually the ones providing the education on the treatment regimens. They're managing the toxicity profiles. They're doing all the coordination of care between visits. They are really going to be the ones telling the patient, 'Hey, you're going to feel good and that's a wonderful thing, but you still need to come once a month or once every six weeks or once every two months for your labs.'" TS 15:17  "It has been amazing. The science, the research, the treatments, the approvals from the U.S. Food and Drug Administration. Survivorship has improved dramatically. Let's take the first few years of the new century, right? The five-year survival rate was about 38%. If you then jump to 2015–2019, which is still seven plus years ago, it has doubled. So, we're talking about anywhere from 60%–80% over a five-year survival. So that's an amazing improvement in their five-year survival rate for myeloma." TS 23:28 "Survivorship in myeloma begins at diagnosis, not just after treatment. And I think that because it is managed as a chronic, often relapsing disease, it does require lifelong evolving care. Patients should realize that they will know us for the rest of their lives. We will know everything about you. I always tell them, 'I will know everything about your hobbies, your children, your grandchildren, what you love to do on the weekends.' It's very important that that point is made right at diagnosis, not just after so many lines of treatment. It's very important that we are going to follow these patients throughout their journey." TS 28:18

Welcome back to season 9! We're kicking it off with my first powerhouse guest, whose mission is to bring clarity, safety, and evidence-based understanding to hyperbaric oxygen therapy and integrative wellness. There is a growing wave of interest in longevity and recovery therapies, but also a lot of confusion and misinformation. She breaks down the science (and safety) of one of the most powerful, foundational tools we have for reducing inflammation, accelerating healing, and supporting long-term health. Nicole Garrett is the CEO of Under Pressure Hyperbarics, a premier hyperbaric oxygen therapy center in Beverly Hills recognized for its clinical-grade safety standards and results-driven approach to wellness. With nearly two decades of experience in hyperbaric medicine, her career began as a commercial diver and dive medic, where she first learned the life-saving applications of pressure and oxygen in extreme environments. Since then, Nicole has helped open and operate HBOT centers across the country and has become a trusted leader in the field. Her work bridges the gap between medical-grade hyperbaric therapy and modern holistic wellness, offering patients a safe and effective path to healing, recovery, and long-term vitality. Nicole is especially passionate about educating clinicians, patients, and the wellness community on the science, indications, and proper protocols behind hyperbaric therapy. Today, she leads a multidisciplinary team at Under Pressure Hyperbarics that supports surgical recovery, sports performance, chronic inflammation, and overall health optimization using hospital-grade chambers and evidence-aligned treatment plans. Connect with Nicole via: Email: nicole@underpressure.com Website: Under Pressure Hyperbarics FB: Under Pressure Hyperbarics IG: @underpressurehyperbarics Linked In: Under Pressure Hyperbarics Gift: A special 15% off first-time HBOT session at Under Pressure Hyperbarics for podcast listeners who mention the Holistic Pharmacy episode. Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Pink Sheet Executive Editor Derrick Gingery and Senior Editor Sue Sutter are joined by special guests Michael Rogers, former US Food and Drug Administration associate commissioner for inspections and investigations, and Douglas Stearn, former principal deputy associate commissioner in the FDA Office of Inspections and Investigations, both now at Canal Row Advisors. They talk about the current state of the agency inspection cadre and resource challenges (1:04) and offer thoughts on the FDA's efforts to increase foreign inspections (25:24), as well as discuss the growing threat that receiving an Official Action Indicated (OAI) classification presents (35:20) and consider whether user fee goals eventually could be impacted (45:02). More On These Topics From The Pink Sheet US FDA Use of ‘Potential Official Action Indicated' Flag Raises Concerns About Facility-Based CRLs: https://insights.citeline.com/pink-sheet/compliance/us-fda-use-of-potential-official-action-indicated-flag-raises-concerns-about-facility-based-crls-3JLUE3CW6BEIFOKQRZ5C4FKFOM/ US FDA's Failure To Implement Key Workforce Reforms Puts Oversight At Risk, GAO Says: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fdas-failure-to-implement-key-workforce-reforms-puts-oversight-at-risk-gao-says-B64V7RAIQNBNBI57ID5ZU3DYAE/ US FDA Remote Assessments Need Clearer Closeout Process, More Transparency, Experts Argue: https://insights.citeline.com/pink-sheet/compliance/manufacturing/us-fda-remote-assessments-need-clearer-closeout-process-more-transparency-experts-argue-4P5UQEPW7NDLNDDQERUQY5Y56M/

In the first episode of Eversio's new Unhinged series, Brandi Garden, Dr. Desiree Caruso, ND, and Samantha Gladish come together for an open and unfiltered conversation about functional mushrooms, health, and the deeper connections between mind, body, and wellness.Samantha's LINKS1. Instagram:https://www.instagram.com/iamsamanthagladish/2. Website: https://www.samanthagladish.com/3. Blog: https://www.samanthagladish.com/blog/TAKE THE QUIZ:If you're not sure where to begin on your mushroom wellness journey, take our Naturopathic Doctor curated Mushroom Wellness QUIZ to find your mushroom match.https://www.eversiowellness.com/pages/take-our-quiz-eversiowellness-youtubeUse code PODCAST15 for 15% off your entire mushroom wellness order at:https://www.eversiowellness.com/discount/PODCAST15JOIN OUR COMMUNITY:Instagram @eversiowellness: https://www.instagram.com/eversiowellness/YouTube @eversiowellness: www.youtube.com/@eversiowellnessTikTok @eversio_wellness: https://www.tiktok.com/@eversio_wellnessFacebook @eversio_wellness: www.facebook.com/eversiowellnessltdQuestions? Contact us here: https://www.eversiowellness.com/pages/contactSign up for our Emails or SMS to be the first to know about product drops, promos, mushroom wellness news!Email List: https://www.eversiowellness.com/pages/sign-up-for-emailsSMS List:https://www.eversiowellness.com/pages/sign-up-for-smsPodcast Website: www.eversiowellness.com for detailed show notesPlease Rate or Share The Eversio Experience Podcast by clicking the 3 dots at the top of the podcast homepage.We appreciate it so much!*The statements, content, and opinions offered in this podcast have not been evaluated by the Food and Drug Administration. The product(s) discussed are not intended to diagnose, treat, cure, or prevent any disease.

The founders of Hershey, Good Humor, Stouffer, Heinz, Kellogg, Kraft, and Birdseye, among others, were pioneers looking to bring clean, hygienic, healthy, and trustworthy products to a market saturated with the opposite. Each specialized in a product, be in chocolate, ice cream, prepared meals, ketchup, cereal, cheese, or frozen foods. Recently we have learned that the grandson of the inventor of Reeses's Peanut Butter cups, owned by Hershey today, has accused the company of destroying the original product, changing "milk chocolate" and "peanut butter" to substances that mirror them. Whereas Milton Hershey sourced fresh milk and used minimal ingredients, modern Hershey products are anything but fresh or even what the label implies. Also, at least 111 substances of unknown safety have been added to foods, drinks and supplements sold in the United States without alerting the US Food and Drug Administration, a new investigation found. This is on top of the exposure that has recently been brought to American foods in general, from food coloring to preservatives - leading companies to change their ingredient lists with a promise of never again lying to consumers. What were companies that attempted to bring purity to a contaminated marketplace, largely resulting from overcrowded cities, has turned ironically into the very thing that they were formed to fight. Now under "trusted brands" the foods that poisons Americans a century ago have made a reemergence.*The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.

Are you treating your Hashimoto's symptoms without ever asking what caused them in the first place? Most women with Hashimoto's spend years chasing symptoms and never get to the real problem. In this episode, we are going upstream. Using the 2010 Deepwater Horizon oil spill as a real-world example, you will see exactly why addressing downstream symptoms without identifying upstream root causes keeps you stuck. Your symptoms are not the problem. They are the result of the problem. In this episode you will learn: Why upstream and root cause mean the same thing and why that matters for your health How your root causes are never just one thing and what to look at instead What your very first step should be after a Hashimoto's diagnosis If you are ready to stop guessing and start identifying your Hashimoto's root causes, this episode is your starting point.

Send a textTurn your expertise into income after 50.  Retirement looks different now. With more women exploring second acts - whether driven by economic shifts, changing timelines, or simply a desire for more - many are asking: Where do I start? The answer may already be in you.In this episode of the Ageless Glamour Girls™ Podcast, we explore how seasoned professionals can reposition decades of experience into authority, income, and impact.  Roz Miller-Choice, founder of The Expert Maker® and author of Know It. Share It. Profit., joins us to discuss:• Why experience may be your greatest untapped asset • Moving from employee thinking to expert positioning • Mindset shifts required to monetize what you know • Why your expertise was never meant to be a best-kept secretIf you're navigating midlife reinvention, career repositioning, or building income after 50, this conversation is for you. Cheers to healthy aging and joyful living, Luvvies!ABOUT OUR GUEST:  Roz Miller-Choice - The Expert Maker® is a personal brand strategist, TEDx speaker, author, and award-winning TV host who helps professionals turn knowledge into credible, profitable brands — earning her the name The Expert Maker®.  A former TV anchor, reporter, and producer with CNN, CBS, NBC, and FOX, Roz combines decades of media experience with entrepreneurship training from Cornell University and Harvard Business School. She is the author of the upcoming book Know It. Share It. Profit.: The 3-Step Branding and Marketing Plan to Turn Your Expertise into Profit and leads a creative team that helps experts build visible, authority-driven brands.Her television series The Expert Maker TV is a winner of the 43rd Annual Telly Awards for branding excellence.                                Guest Links:   Pre-Order Book: https://ksp-book.com/Course: knowitshareitprofit.com TEDx Talk: https://youtu.be/fWcK5itKSSYSpecial thanks to our sponsor, Bricker Labs - makers of Liquid Vitamin B12 Blast and Folic Acid, supporting energy and focus in this season. Visit BrickerLabs.com and use our AGG savings code: AGG10. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.Support the showSupport Ageless Glamour Girls™: www.agelessglamourgirls.com www.linkedin.com/in/marqueetacurtishaynes https://www.shopltk.com/explore/AgelessGlamourGirls https://www.youtube.com/@agelessglamourgirls Instagram @agelessglamourgirls Facebook: https://www.facebook.com/agelessglamourgirls Private (AGG) FB Group: The Ageless Café: https://www.facebook.com/groups/theagelesscafe TikTok: @agelessglamourgirls Podcast Producers: Ageless Glamour Girls™ and Purple Tulip Media, LLC

What if you did absolutely everything right: the hormones, the biohacking, the exercise, the nutrition…and STILL ended up needing hip replacement surgery at 54? That is exactly what happened to gerontologist Zora Benhamou, founder of the Hack My Age podcast, and her story is one of the most important and relevant bone health conversations we have had on this show to date. In this conversation, Zora breaks down the critical difference between osteoporosis (bone density loss) and osteoarthritis (joint degeneration) that too many women (and even many doctors) get completely wrong. She walks through the risk factors that set her up for surgery despite a lifetime of doing things right, what an early warning sign of osteoarthritis actually feels like in your body, and why the DEXA scan your doctor ordered may only be telling you part of the story.  We are discussing the REMS scan, a newer ultrasound technology that measures bone quality and strength rather than just density, and she shares the jaw-dropping story of her husband whose results would have landed him on medication he did not need. She covers the science of what forces bones actually require to rebuild, why jumping off a step beats the treadmill, how hormones and bone health are connected, and what protein and minerals actually have to do with fracture prevention. This is also a conversation about bone loss fear and why understanding the full picture is far more powerful than a single scan result. Key take away: bone loss is not a life sentence. Osteoporosis is reversible. And midlife is exactly the right time to take action.  Learn More About Zora Benhamou Instagram ➜ https://www.instagram.com/hackmyage  Website ➜  https://hackmyage.com  Thank you to our show sponsors! QUANTUM UPGRADE: Try Quantum Upgrade completely free for 15 days—no credit card required. Use code NATALIEJILL at checkout on https://quantumupgrade.io/ TIMELINE: Timeline is offering up to 39% off your order of Mitopure! Go to https://timeline.com/NATALIEJILL   Free Gifts for being a listener of Midlife Conversations! Mastering the Midlife Midsection Guide: https://theflatbellyguide.com/ Age Optimizing and Supplement Guide: https://ageoptimizer.com   Connect with me on social media! Instagram: www.Instagram.com/Nataliejllfit Facebook: www.Facebook.com/Nataliejillfit   For advertising inquiries: https://www.category3.ca/  Disclaimer: Information provided in the Midlife Conversations podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before making any changes to your current regimen.  Information provided in this podcast and the use of any products or services related to this podcast does not create a client-patient relationship between you and the host of Midlife Conversations or you and any doctor or provider interviewed and featured on this show. Information and statements may have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease. Advertising Disclosure: Some episodes of Midlife Conversations may be sponsored by products or services discussed during the show. The host may receive compensation for such advertisements or if you purchase products through affiliate links. Opinions expressed about products or services are those of the host and/or guests and do not necessarily reflect the views of any sponsor. Sponsorship does not imply endorsement of any product or service by healthcare professionals featured on this podcast.

When motivation rises, intensity often follows — but more isn't always better. Episode #247

Hey Mama,  Have you ever wondered why you should make time for exercise? Some exercise for health, or to look a certain way, but have you ever considered exercising to manage your stress levels? Over the past few weeks we have been focusing on simple, stackable foundational habits that will help you prepare your body to better receive and manage stress. Exercise is one of the foundational habits you must incorporate to manage stress naturally. And, as Christian Moms, we are called to do everything for God's glory. (Colossians 3:17)  So, how can exercise glorify God? Listen in to today's episode as we re-visit part one of my interview with Certified Fitness Instructor, Certified Natural Health Practitioner, and Sister in Christ, Annemarie Dalton for expert insight.   For His Glory, Christen   I would love to hear from you!  >>Leave a Review >>Connect with me:   Sign Up for Manage In The Moment Coaching Call: https://bit.ly/ManageStressInTheMoment   Email me : naturalwellnessforbusymoms@gmail.com  Sign Up to Become an Insider: https://bit.ly/naturalwellnessinsider  Join Our FREE Facebook Community:https://www.facebook.com/groups/1789472588229094  >>Find Related Products Here: https://bit.ly/m/Natural-Wellness-for-Busy-Moms  >> These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. >>I make a small commission when using the links above to purchase items.

What if the reason time feels like it is speeding up has nothing to do with getting older, and everything to do with how you are living? In this episode of Midlife Conversations, we sit down with world-class event coordinator Jessie Schwartzburg for an energizing and practical conversation about taking time to enjoy your time in midlife. Jessie has spent decades designing unforgettable experiences for high-profile clients, bucket-list travel groups, and corporate powerhouses, and her brain works in a way that will genuinely change how you think about your days. We explore why our brains create such vivid memories during new experiences, how small intentional touches can transform an ordinary moment into something people talk about for years, and what it actually takes to stop feeling like life is passing you by. Jessie also breaks down her personal formula for structuring any day or any trip around the four things she believes are the secret to a long, vibrant life: movement, learning, adventure, and connection. You will walk away with practical, immediately actionable ideas, from planning a memorable birthday lunch to finally booking that group trip you have been putting off. This one is a genuine reset for how you are choosing to spend your time in midlife.  

Angela talks to Professor Stuart Philips, who challenges the long-standing "Anabolic Window" myth, revealing that muscle sensitivity to protein actually lasts up to 48 hours post-exercise rather than a mere 30-minute window.  The conversation cuts through the noise of modern protein obsession, establishing that while the RDA is a baseline, the true sweet spot for muscle synthesis lies between 1.2g and 1.6g per kilogram of body weight. WHAT YOU'LL LEARN: The protein "sweet spot": While the baseline requirement is 0.8g/kg, optimal benefits for muscle maintenance and growth occur between 1.2g and 1.6g per kilogram. The myth of the 30-minute window: The "Anabolic Window" is much larger than previously thought; muscles remain sensitive to protein for up to 48 hours after a workout. Dosage limits: For most people, including perimenopausal and postmenopausal women, 30g to 40g of protein per meal is the effective limit for stimulating new muscle growth. Carbohydrates are essential: Despite modern "carb-phobia," carbohydrates are the primary drivers of high-intensity performance TIMESTAMPS [01:50] The confusion between calculating protein [03:52] The "Baking the Cake" analogy [05:54] Debunking the idea that you can only absorb 20g of protein at a time. [07:18] Addressing Anabolic Resistance and protein needs for women in menopause. VALUABLE RESOURCES ⁠Join The High Performance Health Community⁠ ⁠Click here⁠ for discounts on all the products I personally use and recommend A BIG thank you to our sponsors who make the show possible *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. ABOUT THE HOST Angela Foster is an award winning Nutritionist, Health & Performance Coach, Speaker and Host of the High Performance Health podcast. A former Corporate lawyer turned industry leader in biohacking and health optimisation for women, Angela has been featured in various media including Huff Post, Runners world, The Health Optimisation Summit, BrainTap, The Women's Biohacking Conference, Livestrong & Natural Health Magazine. Angela is the creator of BioSyncing®️ a blueprint for ambitious entrepreneurial women to biohack their health so they can 10X how they show up in their business and their family without burning out. CONTACT DETAILS ⁠Instagram⁠ ⁠Facebook⁠ ⁠LinkedIn⁠ Disclaimer: The High Performance Health Podcast is for general information purposes only and do not constitute the practice of professional or coaching advice and no client relationship is formed. The use of information on this podcast, or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for medical or other professional advice, diagnosis, or treatment. Users should seek the assistance of their medical doctor or other health care professional for before taking any steps to implement any of the items discussed in this podcast. This Podcast has been brought to you by Disruptive Media. ⁠https://disruptivemedia.co.uk/

Have you ever left a doctor's appointment with a prescription but still felt like something was missed? If you have Hashimoto's, you are not alone. In this episode, Dr. Aaron Hartman, a triple board-certified physician, breaks down why bad medical advice and Hashimoto's are more connected than most patients realize, and exactly what you can do about it. You will learn: Why medical error affects autoimmune patients more than you think The four root causes behind every autoimmune disease What kind of provider to look for when you feel stuck Hit play to get started.   Episode 129 about LDN with Pharmacist Steve Anderson   Dr. Hartman's book "UnCURABLE - From Hopeless Diagnosis to Defying All Odds"   JOIN THE HEALTH WITH HASHIMOTO'S COMMUNITY Unlock your wellness journey with the free Health with Hashimoto's community! Join a supportive community that's here for you every step of the way. The Health with Hashimoto's community is on Skool: https://www.skool.com/health-with-hashimotos/about   Find all links on my resource page: https://healthwithhashimotos.com/resources/   ABOUT THE PODCAST & ESTHER: The Health with Hashimoto's podcast will help you explore the root causes of your autoimmune condition and discover holistic solutions to address your Hashimoto's thyroiditis. It is hosted by Esther Yunkin, a registered nurse, holistic health educator, and Hashimoto's warrior.   This podcast is for informational and educational purposes. Please discuss any questions or concerns with your healthcare professional. These statements have not been evaluated by the Food and Drug Administration. Products mentioned are not intended to diagnose, treat, cure or prevent any disease.

American officials say they believe China held a nuclear test in 2020, and President Trump reserves the right to do the same, as the New Start arms-control treaty with Russia hits its expiration date this month. Plus, the Food and Drug Administration summarily rejects a flu vaccine from Moderna, before changing course. Learn more about your ad choices. Visit megaphone.fm/adchoices

What if the reason you still feel off (despite trying every diet, supplement, routine, and hormone protocol) is that nobody has ever treated your body as the energy system it actually is? In this conversation, Allison Maslan, who is a classically trained homeopath, founder of Pinnacle Global Network, and a Wall Street Journal bestselling author dives into a conversation that goes far beyond conventional health advice. Allison spent 20 years running her own homeopathic practice, treated thousands of patients, and founded the first homeopathic college in Southern California. She's also in her early 60s, flies trapeze, and is proof that your most powerful chapter can start in midlife. We unpack what homeopathy actually is and why it's been written out of mainstream American medicine, how it can support women navigating menopause and perimenopause (especially those who can't or don't want to use hormones), the science of why your brain literally cannot tell the difference between a vivid visualization and reality, the 1980s study that proved men in their 70s and 80s can physically reverse aging through mindset alone, and Allison's exact Vision Crafting process – the morning ritual she uses to manifest everything from her dream home to business breakthroughs. This episode is for the woman who is tired of only playing defense with her health and is ready to start playing offense with her life with real, science-backed mechanics of how your brain shapes your body and what you can do with that tomorrow morning.  

What really happens when you try to quit sugar — and why perfection isn't required to experience freedom. Episode #246

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: big updates for stem cell and islet transplants, new pen option for Zepbound, an implantable insulin pump moves forward and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Quick reminder: I'm just back from MNO DC and I'm exhausted. But it's the best kind of tired. We had an incredible time – hope you can join us in Nashville. With a reminder that we have our first Club 1921 in Nashville – that's our educational dinner series for HCPs and patient leaders. All the info is over at diabetes-connections.com events/     Okay.. our top story this week: XX An "immune system reset" eliminated Type 1, diabetes in mice in a study conducted at Stanford Medicine without immune suppressant medications. This was a combined transplant of blood stem cells and insulin-producing pancreatic islet cells from a donor whose immune profile did not match the recipient. The dual transplant approach both restored insulin production and retrained the immune system. For the full six months of the experiment, the animals did not need insulin injections or immune suppressive medications. Challenges remain using this approach to treat Type 1 diabetes. Pancreatic islets can be obtained only after death of the donor, and the blood stem cells must come from the same person as the islets. It is also unclear whether the number of islet cells typically isolated from one donor would be enough to reverse established Type 1 diabetes. But the researchers are working on solutions, which could include generating large numbers of islet cells in the laboratory from pluripotent human stem cells, or finding ways to increase the function and survival of transplanted donor islet cells. https://scitechdaily.com/stanford-scientists-cure-type-1-diabetes-in-mice-without-insulin-or-immune-suppression/ XX An electronic implant interlaced with islet cells is being looked at to treat type 1. Researchers at the University of Pennsylvania School of Medicine worked with engineers at Harvard University to combine stem-cell biology with soft electronics. They inserted an ultrathin, flexible mesh of conductive wires — thinner than a human hair — into developing pancreatic tissue. As the cells assembled into clusters, the mesh became woven through them. The electronics can record the faint electrical signals produced by the cells that control insulin release. They can also deliver small pulses of electricity back to the cells.   After several days, the cells began to behave more like mature islets. Their internal signalling shifted, neighbouring cells started working in concert and insulin release became stronger and better timed.  Very early on here – and the transplanted cells still need to be protected from being attacked by the immune system. https://www.thetimes.com/uk/science/article/first-cyborg-pancreas-implants-type-1-diabetes-nxkv8r0fp?gaa_at=eafs&gaa_n=AWEtsqeJYYUF9TMR-GgGUG92hPyog-ISeiqGIgdyaaIKKcpvhtoftGiUaaOtQeG0NWI%3D&gaa_ts=699c50d4&gaa_sig=w-PQ0ArosZSznYDSWEzt8aQg4WC0FF5ZFRt9NedO5sSTL2FyWzupH8eSG7RCy2S8TQnlHOeKCudANWm1MNI59w%3D%3D XX Katie Beth (hand) Eledon trial – aaron kowalski post linkedin. Last fall we told you about promising results from Eledon's drug to prevent islet transplantation rejection in type 1 diabetes. The first six patients no longer had to inject or infuse insulin.. the trials continue and this month one of the patients – Katie Beth Hand – began posting about her experiences one month in, on social media, she says she's off basal insulin already and in range 99 percent of the time. She is also encouraging people to learn more about support the islet act https://lnkd.in/e8pQ7_Y7 XX This is a bill introduced last November which would change the wording on pancreatic cell transplants. The problem is that islets are classified as drugs rather than organs, making transplantations difficult for medical teams and centers to preform due to accessibility. Insurance companies are also less likely to provide reimbursements for treatment, which can cost hundreds of thousands of dollars. The official Journal of The Transplantation Society estimates the cost at about $140,000. The bill went to the senate committee of Health, Education, Labor, and Pensions in early November. No other action has been taken since then. https://www.wtoc.com/2026/02/19/bluffton-family-advocates-islet-act-help-diabetic-son/ XX Big change for the obesity drug Zepbound – now available in the multi dose KwikPen. This is a month's worth of doses in a single pen.. and it's multi dose – you can adjust it. Cash-paying patients can get the multi-dose device, called KwikPen, on the company's direct-to-consumer website, LillyDirect. Prices start at $299 per month for the lowest dose level. Until now, you could only get zepbound in a single dose auto injector or a sing dose vial. In a release, Lilly said the Food and Drug Administration approved a label expansion for Zepbound to include the multi-dose device. The KwikPen is already used for other drugs, such as Lilly's popular diabetes medication, Mounjaro – which is the same medication as zepbound, they're both tirzepitide. https://www.cnbc.com/2026/02/23/eli-lilly-launches-zepbound-obesity-drug-pen-one-month-doses.html   XX For years, researchers have observed that people who live at high elevations,  tend to develop diabetes less often than those at sea level. Although the trend was well documented, the biological explanation behind it was unclear. Scientists now say they have identified the reason. Their research shows that in low oxygen environments, red blood cells begin absorbing large amounts of glucose from the bloodstream. Their work showed that when oxygen is limited, red blood cells use glucose to generate a molecule that helps release oxygen to tissues. This process becomes especially important when oxygen is in short supply. The researchers also found that the metabolic benefits of prolonged hypoxia lasted for weeks to months after mice were returned to normal oxygen levels. They then evaluated HypoxyStat, a drug recently developed in Jain's lab that mimics low oxygen exposure. HypoxyStat is taken as a pill and works by causing hemoglobin in red blood cells to bind oxygen more tightly, limiting the amount delivered to tissues. In mouse models of diabetes, the medication completely reversed high blood sugar and outperformed existing treatments. https://www.sciencedaily.com/releases/2026/02/260221060952.htm XX Watching this one closely – Portal Diabetes gets FDA breakthrough device designation for its implantable insulin pump system. This is a system that includes not just a device that's implanted into the abdomen, but also a new, temperature stable insulin. It will work with – quote – "modern" CGM technology with a fully closed loop - and aims to deliver a functional cure for type 1. While reports say Portal's system is the first in the US – there was an implantable pump developed and used by about 500 people worldwide, including about 100 in the US – by MiniMed. Medtronic bought the company and in 2007 they stopped that program. Portal Diabetes expects to begin clinical trials on its combination system around the fourth quarter of 2027. https://www.drugdeliverybusiness.com/portal-diabetes-fda-breakthrough-implantable-insulin-pump/ XX Sequel Med Tech and Senseonics (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration. That's the eversense cgm and twist pump. Sequel said its full launch with Eversense 365 makes twiist available with two compatible CGMs. twiist also pairs with the Abbott FreeStyle Libre 3 Plus sensor. Eversense 365, an implantable system, rests under the skin for the duration of a year. Users can change its external, silicone-based adhesive daily with almost no skin reactions. https://www.drugdeliverybusiness.com/sequel-senseonics-full-launch-twiist-eversense/ XX Right back with a Dexcom update, and a look at which type of diet reduces insulin use overall.. right after this: -- Back to the news.. Dexcom is watching for expanded Medicare coverage of its continuous glucose monitors to people with Type 2 diabetes who don't take insulin. CEO Jake Leach told investors on Thursday that the company has been "sitting here waiting for a coverage decision" from the Centers for Medicare and Medicaid Services Dexcom started to see commercial coverage unlock for Type 2, non-insulin users toward the end of last year, Leach said. He expects broader Medicare coverage for that group would allow nearly 12 million people to access CGMs.     In the meantime, the American Diabetes Association updated its guidelines last year to recommend clinicians consider using CGMs for Type 2 diabetes when patients are taking glucose-lowering medications other than insulin. Leach said that real world data the company has been generating supports that decision, and that Dexcom has launched a registry for non-insulin users. https://www.medtechdive.com/news/dexcom-seeks-expanded-medicare-coverage-of-cgms-for-type-2-diabetes/812223/ XX Medtronic's separation of MiniMed is not yet complete.. but continues to move forward. The company has submitted their next pump – MiniMed Flex – to the FDA. This is a pump smaller than the 780G but uses the same reservoirs and infusion sets. It will also work with both the Simplera Sync and Instinct sensors. Medtronic also began a U.S. pivotal study for Vivera, its third-generation algorithm for automated insulin delivery. It also remains set to submit its MiniMed Fit patch pump system to the FDA by the coming fall. https://www.drugdeliverybusiness.com/medtronic-submits-minimed-flex-fda-q3/ XX A study modelling how genes may influence a child's body mass index over time has found that BMI at age 10 and overall growth rate between ages one and 18 might be important factors, as the two are more likely linked to diabetes, high cholesterol, and heart disease in later life. Nearly 66,000 BMI measurements from around 6,300 children and adolescents aged one to 18 were analysed to understand the role of genes.     "Future research is needed to help identify the most effective ages to prevent obesity or poor growth for long-term benefit." https://www.ndtv.com/health/bmi-at-age-10-growth-rate-up-to-age-18-are-important-factors-for-diabetes-heart-disease-study-11125146 XX A low-fat vegan diet—without cutting calories or carbs—may help people with type 1 diabetes significantly reduce how much insulin they need. In a new analysis published in BMC Nutrition, participants following the plant-based plan lowered their daily insulin use by 28%, while those on a portion-controlled diet saw no meaningful change. Researchers say the reduced insulin requirement likely reflects improved insulin sensitivity. The original 2024 study reported additional benefits from the vegan diet. Participants lost an average of 11 pounds and showed improvements in insulin sensitivity and glycemic control. Cholesterol levels and kidney function also improved among those following the plant-based plan. https://www.sciencedaily.com/releases/2026/02/260212234212.htm XX Interesting little tidbit from the Winter Olympic Games.. the World Anti-Doping Agency (WADA) was monitoring GLP drug use. An advisory group that makes recommendations about WADA's list of prohibited substances discussed the status of GLP-1 medications, and added semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) to its monitoring program That means patterns of use of these drugs will be tracked both in and out of competition.  The finding will be used to make recommendations about whether GLP-1 agonists should be added to the prohibited list, the spokesperson explained. While GLP-1 drug use is not currently prohibited, that could change before the next Summer Olympic Games in Los Angeles in 2028, he noted. https://www.medpagetoday.com/popmedicine/cultureclinic/119770 XX That's it for in the news!

It has now been one year of the second Trump administration, with many attacks to sexual and reproductive health, rights, and justice aligning entirely with Project 2025's blueprint. Amy Friedrich-Karnik, Director of Federal Policy at the Guttmacher Institute and Anna Bernstein, Principal Federal Policy Advisor at the Guttmacher Institute, sit down to talk with us about the year's assaults on sexual and reproductive health and rights, LGBTQI+ rights, and science and healthcare by the Trump administration. From day one of their return to office, protections for abortion access put in place by the Biden administration were rolled back. This included several protections for privacy, emergency care, and veteran's access. President Trump immediately pardoned anti-abortion activists who had previously violated the FACE (Freedom of Access to Clinic Entrances) Act and has stopped enforcing the act in most places. Anti-science rhetoric increases, with the Food and Drug Administration endorsing junk-science against mifepristone-- one of the drugs used in a medication abortion. To promote mis- and disinformation, data sets, research, and websites were removed from the internet. The passage of the One Big Beautiful Bill Act defunded Planned Parenthood and set work restrictions on Medicaid coverage. Additionally, the administration froze Title X funding, expanded the already-expanded Global Gag Rule, and issued endless attacks to the transgender community.For more information, check out Future Hindsight: https://www.futurehindsight.com/Support the showFollow Us on Social: Twitter: @rePROsFightBack Instagram: @reprosfbFacebook: rePROs Fight Back Bluesky: @reprosfightback.bsky.social Buy rePROs Merch: Bonfire store Email us: jennie@reprosfightback.comRate and Review on Apple PodcastThanks for listening & keep fighting back!

For people living with osteoarthritis, news about potential new treatments often comes with more questions than answers. In this episode of The Health Advocates, we slow things down to explain what it really means when a company submits a New Drug Application, or NDA, to the U.S. Food and Drug Administration. Steven Newmark is joined by Erich Horsley and Dr. Yusuf Yazici from Biosplice Therapeutics to walk through this important regulatory milestone and why it matters for patients. Together, they break down what an NDA is, what happens during FDA review, and what patients should and should not expect while a therapy is under evaluation. The conversation also explores the current osteoarthritis treatment landscape, why progress in this disease has been so challenging, and what researchers mean when they talk about disease-modifying approaches. Contact Our HostSteven Newmark, Chief of Policy at GHLF: snewmark@ghlf.orgA podcast episode produced by Ben Blanc, Director, Digital Production and Engagement at GHLF.We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.orgListen to all episodes of The Health Advocates on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

About this episode: A recent analysis of FDA documents has found that the agency has historically regulated mifepristone—a medication commonly used to terminate pregnancy—based on available scientific evidence and without ideological bias. In this episode: Caleb Alexander, an author of the study, discusses these findings and their implications for a possible new review of the medication by FDA. Guests: Dr. G. Caleb Alexander, MS, is a practicing internist and drug safety expert at the Johns Hopkins Bloomberg School of Public Health. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: The US Food and Drug Administration's Regulation of Mifepristone—JAMA Study: FDA Regulation of Abortion Drug Mifepristone from 2011 to 2023 Shaped by Evidence and Caution—Johns Hopkins Bloomberg School of Public Health F.D.A. Decisions on Abortion Pill Were Based on Science, New Analysis Finds—New York Times What Is Mifepristone, aka "The Abortion Pill"?—Johns Hopkins Bloomberg School of Public Health What's at Stake for Access to Medication Abortion and the FDA in the Supreme Court Case FDA v. the Alliance for Hippocratic Medicine?—KFF Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Hey Mama,  Do you want to learn how to find time to exercise as a busy mom? Studies show moving your body is not only essential for your physical health, but also for your mental health. As moms, it can be difficult to find the time to exercise with all of the responsibilities we have.  Maybe you know exercise is good for you, but you are not sure where to start. Maybe you desire to be active like you used to, but your body is different, and you can't do what you used to.  No matter your age and stage, Mama, you can move your body and you should move your body because movement improves your mental health. Your mental health matters, for you and your family. Join me today as I share with you three practical tips to make time for exercise as a busy mom.   For His Glory, Christen   I would love to hear from you!  >>Leave a Review >>Connect with me:   Sign Up for Manage In The Moment Coaching Call: https://bit.ly/ManageStressInTheMoment   Email me : naturalwellnessforbusymoms@gmail.com  Sign Up to Become an Insider: https://bit.ly/naturalwellnessinsider  Join Our FREE Facebook Community:https://www.facebook.com/groups/1789472588229094  >>Find Related Products Here: https://bit.ly/m/Natural-Wellness-for-Busy-Moms  >> These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. >>I make a small commission when using the links above to purchase items.

Today's Headlines: Billionaire retail mogul Les Wexner testified before Congress about his ties to Jeffrey Epstein — but instead of appearing on Capitol Hill, lawmakers traveled to his Ohio mansion, where the 88-year-old was deposed with family members present. Notably, no Republicans on the House Oversight Committee showed up. Wexner, who once granted Epstein power of attorney, said he was “naive, gullible, and foolish” and claimed he was conned, despite building a multibillion-dollar empire. It wasn't the only billionaire hot seat of the day. Mark Zuckerberg testified in a landmark trial against Meta over allegations the company knowingly made its platforms addictive and harmful to children. The case could influence more than 1,500 pending social media addiction lawsuits. Meanwhile, The New York Times reported Meta has set aside $65 million to back state-level politicians friendly to the AI industry through new super PACs in Illinois and Texas — timing that feels… strategic. In federal agency cleanup news, the U.S. Food and Drug Administration removed a webpage warning against bogus autism “treatments” like chlorine dioxide and raw camel milk, calling it routine housekeeping. On the foreign policy front, Donald Trump met with advisers to discuss Iran, as mixed signals emerge from nuclear talks in Geneva and two U.S. aircraft carriers sit in the Mediterranean. The administration also plans to withdraw roughly 1,000 U.S. troops from Syria over the next two months, though officials say the move is “conditions based.” Meanwhile, a potential U.S. arms sale to Taiwan is reportedly in limbo ahead of Trump's planned meeting with Xi Jinping in Beijing. Back home, New York City Mayor Zohran Mamdani announced the city will resume clearing homeless encampments following at least 19 deaths during a recent cold snap, with outreach led by homeless services rather than police. Resources/Articles mentioned in this episode: AP News: Billionaire Les Wexner says he was 'duped' by adviser Jeffrey Epstein, 'a world-class con man' Axios: Zuckerberg testifies in landmark social media addiction trial NYT: Meta Begins $65 Million Election Push to Advance A.I. Agenda ProPublica: Chlorine Dioxide, Raw Camel Milk: The FDA No Longer Warns Against These and Other Ineffective Autism Treatments Axios: Trump meets with top Iran advisers as war threat grows WSJ: U.S. Is Withdrawing All Forces From Syria, Officials Say WSJ: U.S. Arms Sale to Taiwan in Limbo Amid Pressure Campaign From China AP News: Mamdani reboots homeless encampment sweeps in New York City Subscribe to the Betches News Room and join the Morning Announcements group chat. Go to: ⁠⁠⁠betchesnews.substack.com Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices

The twists and turns continue at the nation's health agency, where this week's announcements included notice that the Food and Drug Administration will review Moderna's new flu vaccine after all and that a handful of top agency officials are getting new jobs.Those developments and others can be traced to a White House looking to shake things up before the midterms — and win over voters on health care. Tami Luhby of CNN, Shefali Luthra of The 19th, and Lauren Weber of The Washington Post join KFF Health News' Mary Agnes Carey to discuss these stories and more. Visit our website for a transcript of this episode.Plus, for “extra credit” the panelists suggest health policy stories they read this week that they think you should read, too:  Mary Agnes Carey: Politico's “Why Congress Failed To Reach an Obamacare Deal,” by Robert King and Simon J. Levien. Lauren Weber: NiemanLab's “The Atlantic's Elizabeth Bruenig on Her ‘Hypothetical,' Heavily Reported Measles Essay,” by Laura Hazard Owen. Tami Luhby: The City's “NewYork-Presbyterian Nurses Reject Contract by Overwhelming Margin,” by Claudia Irizarry Aponte and Ben Fractenberg. Shefali Luthra: NPR's “Minneapolis Doctors Warn of Lasting Medical Effects, Even After ICE Agents Leave,” by Jasmine Garsd. 

The Food and Drug Administration agreed to begin a review of biotech company Moderna's application to make a new seasonal flu shot available. The decision comes after the FDA initially refused to review the company's application. It's a back and forth that reveals increased turmoil within the agency. WSJ's Liz Essley Whyte takes us inside the FDA's unexpected reversals and explores what's next for the mRNA flu vaccine. Jessica Mendoza hosts.  Further Listening: - The FDA Commissioner on Vaccines and Public Trust - Breakfast Battle: The Cereal Industry vs MAHA Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

A partial government shutdown is impacting the Department of Homeland Security, leaving essential personnel to work without pay as Republicans and Democrats remain divided over funding. The debate intensified following controversial immigration enforcement actions in Minneapolis & Los Angeles that have sparked anti-ICE protests and demands for stricter oversight of federal agents. Rep.Tony Gonzales (R-TX), whose district covers 800 miles of the southern border, joins to discuss the DHS funding standoff, the focus on the removal of criminal illegal aliens, and why he believes the border is more secure now than under the previous administration.The Trump administration is once again taking a closer look at the American diet and what's in it. As part of the Department of Health and Human Services “Make America Healthy Again” agenda, the Food and Drug Administration is targeting the longstanding “Generally Recognized as Safe” (GRAS) rule, which allows food companies to self-certify ingredients without federal oversight. FDA Deputy Commissioner for Human Foods Kyle Diamantas joins the Rundown to discuss how Americans can avoid potentially harmful processed ingredients and the steps Washington is taking to eliminate them. Plus, commentary by FOX News Contributor, Richard Fowler. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In 1980, toxic shock syndrome (TSS) emerged as a public health crisis among women who used tampons. There were hundreds of cases, and The Centers for Disease Control linked deaths from TSS to super-absorbent tampons.The Food and Drug Administration responded by assembling a ‘Tampon Task Force' in 1982 to develop safety standards. A researcher called Nancy King Reame was recruited to run the independent laboratory testing. Her work helped establish the first national absorbency standards for tampons. Golda Arthur speaks to Nancy King Reame. Eye-witness accounts brought to life by archive. Witness History is for those fascinated by the past. We take you to the events that have shaped our world through the eyes of the people who were there. For nine minutes every day, we take you back in time and all over the world, to examine wars, coups, scientific discoveries, cultural moments and much more. Recent episodes explore everything from the death of Adolf Hitler, the first spacewalk and the making of the movie Jaws, to celebrity tortoise Lonesome George, the Kobe earthquake and the invention of superglue. We look at the lives of some of the most famous leaders, artists, scientists and personalities in history, including: Eva Peron – Argentina's Evita; President Ronald Reagan and his famous ‘tear down this wall' speech; Thomas Keneally on why he wrote Schindler's List; and Jacques Derrida, France's ‘rock star' philosopher. You can learn all about fascinating and surprising stories, such as the civil rights swimming protest; the disastrous D-Day rehearsal; and the death of one of the world's oldest languages.(Photo: Tampons. Credit: Getty Images)

What if everything the government told you to eat for 30 years was literally backwards? If you're over 45 and you've been confused by decades of conflicting nutrition advice, this conversation is for you. You've been told to eat fat-free and then full-fat. You've been told carbs are evil and then that you need them. The food pyramid told us to load up on bread, pasta, and rice while keeping fat to a bare minimum. We followed that advice. And we got fatter, sicker, and more inflamed than ever. Now the entire framework has been flipped upside down.  This isn't your fault. The recommendations actually were wrong, and they're finally correcting course. Nutrition has somehow become political. The real reason the old food pyramid was designed the way it was has nothing to do with what's actually healthy for your body. Spoiler alert: it was about fear of fat, preventing deficiency, and keeping people fed cheaply. Optimization? That wasn't even on the radar. In this episode, Natalie sits down with registered dietitian Keri Glassman to break down the 2025 dietary guidelines, how the government's shift from "preventing disease" to "supporting optimal health" changes literally everything about nutrition that we've seen for decades, the specifics that the new guidelines finally got right (and the nuances they still missed), the seed oil debate and what actually matters, how GP1's are becoming genuinely life-changing for some women, and why the glamorization of eating disorders on social media connected to these drugs is deeply concerning…and more!  But understanding what changed is only half the battle. The bigger conversation is about learning to trust your own body's signals, understanding that your nutrition needs over 45 are different than at 25, and finding what actually works for YOUR individual situation instead of following yet another set of rules.   Catch the full episode on YOUTUBE HERE: https://bit.ly/MidlifeConversationsYouTube    Learn More About Keri Glassman Instagram ➜ https://www.instagram.com/keriglassman  Website ➜  https://nutritiouslife.com/  Thank you to our show sponsors! BIOPTIMIZERS: Get the digestive enzymes I take with every meal here https://www.bioptimizers.com/nataliejill  Free Gifts for being a listener of Midlife Conversations! Mastering the Midlife Midsection Guide: https://theflatbellyguide.com/ Age Optimizing and Supplement Guide: https://ageoptimizer.com   Connect with me on social media! Instagram: www.Instagram.com/Nataliejllfit Facebook: www.Facebook.com/Nataliejillfit   For advertising inquiries: https://www.category3.ca/  Disclaimer: Information provided in the Midlife Conversations podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before making any changes to your current regimen.  Information provided in this podcast and the use of any products or services related to this podcast does not create a client-patient relationship between you and the host of Midlife Conversations or you and any doctor or provider interviewed and featured on this show. Information and statements may have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease. Advertising Disclosure: Some episodes of Midlife Conversations may be sponsored by products or services discussed during the show. The host may receive compensation for such advertisements or if you purchase products through affiliate links. Opinions expressed about products or services are those of the host and/or guests and do not necessarily reflect the views of any sponsor. Sponsorship does not imply endorsement of any product or service by healthcare professionals featured on this podcast.  

The U.S. Food and Drug Administration announced recently that it will not review Moderna's mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and outside the industry concerned about the Trump administration's approach to vaccine development and recommendations. Amna Nawaz discussed more with Michael Osterholm. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Why shorter fasts often stop working once insulin resistance is established — and what therapeutic fasting is actually designed to do. Episode #245